Evidence map›Paper›PMID 30621191›Full record

ArticleInternational journal of environmental research and public health2019

Mortality Due to Cystic Fibrosis over a 36-Year Period in Spain: Time Trends and Geographic Variations.

Ana Villaverde-Hueso, Germán Sánchez-Díaz, Francisco J Molina-Cabrero, Elisa Gallego, Manuel Posada de la Paz, Verónica Alonso-Ferreira

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Managing Cystic Fibrosis in Polish Healthcare.International journal of environmental research and public health · 2020
    Article
  4. Cystic fibrosis-related mortality trends in Brazil for the 1999-2017 period: a multiple-cause-of-death study.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana Villaverde-HuesoInstitute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, 28029 Madrid, Spain. anavillaverde@isciii.es.
Germán Sánchez-DíazInstitute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, 28029 Madrid, Spain. g.sanchez@externos.isciii.es.ORCID 0000-0003-2686-7545
Francisco J Molina-CabreroDepartment of Preventive Medicine, Complejo Hospitalario Universitario de Albacete, 02006 Albacete, Spain. fmolinac@sescam.jccm.es.
Elisa GallegoDepartment of Preventive Medicine, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain. elisa.gallego@salud.madrid.org.
Manuel Posada de la PazInstitute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, 28029 Madrid, Spain. mposada@isciii.es.ORCID 0000-0002-8372-4180
Verónica Alonso-FerreiraInstitute of Rare Diseases Research (IIER), Instituto de Salud Carlos III, 28029 Madrid, Spain. valonso@isciiii.es.ORCID 0000-0002-8560-1336

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study is to analyze population-based mortality attributed to cystic fibrosis (CF) over 36 years in Spain. CF deaths were obtained from the National Statistics Institute, using codes 277.0 from the International Classification of Diseases (ICD) ninth revision (ICD9-CM) and E84 from the tenth revision (ICD10) to determine the underlying cause of death. We calculated age-specific and age-adjusted mortality rates, and time trends were assessed using joinpoint regression. The geographic analysis by district was performed by standardized mortality ratios (SMRs) and smoothed-SMRs. A total of 1002 deaths due to CF were identified (50.5% women). Age-adjusted mortality rates fell by -0.95% per year between 1981 and 2016. The average age of death from CF increased due to the annual fall in the mortality of under-25s (-3.77% males, -2.37% females) and an increase in over-75s (3.49%). We identified districts with higher than expected death risks in the south (Andalusia), the Mediterranean coast (Murcia, Valencia, Catalonia), the West (Extremadura), and the Canary Islands. In conclusion, in this study we monitored the population-based mortality attributed to CF over a long period and found geographic differences in the risk of dying from this disease. These findings complement the information provided in other studies and registries and will be useful for health planning.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolCystic FibrosisFemaleGeographyHumansInfantInfant, NewbornMaleMiddle AgedMortalitySpaincystic fibrosisgeographic analysismortality trendspopulation-based mortality

Identifiers

PMID30621191
PMCPMC6338987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.